Gel Documentation Systems Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gel Documentation Systems Market Analysis
The gel documentation systems market is expected to register a CAGR of 4.1% over the forecast period.
- The gel documentation systems market experienced moderate growth initially when the COVID-19 pandemic began. The high demand for gel documentation systems to analyze protein or nucleic acid bands, including a low-cost and highly sensitive method for detecting SARS-CoV-2, drove this growth. However, the pandemic caused a temporary dip in non-COVID-related research, shifting the focus of the research community, healthcare, and pharma players. As a result, the COVID-19 outbreak moderately impacted the market growth in its preliminary phase. Nonetheless, the market is expected to grow steadily due to increasing research and diagnosis activities for various medical conditions worldwide.
- The prevalence of infectious diseases and genetic disorders and increasing research investments in genomics and proteomics techniques are boosting the growth of the gel documentation systems market. With the growing number of cancer cases worldwide, the demand for gel documentation systems for research applications is expected to increase. For example, according to data published by the Australian Institute of Health and Welfare in June 2022, over 158,530 cases were diagnosed in 2021, and the number of cases of cancer diagnosed increased to 162,163 in Australia in 2022. This increasing prevalence of chronic diseases is expected to drive the growth of the gel documentation system market during the forecast period. Additionally, research collaborations are increasing, which is also expected to boost the demand for gel documentation systems. For example, in February 2023, the University of Texas MD Anderson Cancer Center announced a strategic collaboration with biotech company Xilis to accelerate the development of novel cancer therapies using Xilis' proprietary MicroOrganoSphere (MOS) technology.
- Moreover, in January 2022, Eli Lilly and Company acquired exclusive rights to Entos Pharmaceuticals' Fusogenix nucleic acid delivery technology. This acquisition would allow both companies to initiate the research, development, and commercialization of nucleic acid products that target the central and peripheral nervous systems. Eli Lilly will have access to a novel delivery platform technology that can address the challenges of nucleic acid therapeutic modalities, thus contributing to the market's growth. Such developments are expected to increase the demand for research on nucleic acids and proteins, which require gel documentation systems, thus driving the market's growth.
- In conclusion, the gel documentation systems market is anticipated to grow over the analysis period due to the increasing prevalence of diseases and research developments. However, the growing adoption of alternative techniques may impede the market's growth.
Gel Documentation Systems Market Trends
The Nucleic Acid Quantification Segment is Expected to Witness Significant Growth Over the Forecast Period
- Nucleic acid quantification is a technique used to determine the amount of nucleic acid present in a solution by using gel electrophoresis to separate the target nucleic acid band according to the molecular weight of the nucleic acid segments in the band. The quantity of the target nucleic acid band is determined by visualizing the nucleic acid bands under a gel documentation system and comparing them with the nucleic acid ladder. This technique is essential for various research studies involving the determination of the molecular weight of nucleic acids such as DNA and RNA. It has several applications in amplification, genetic engineering, and other fields.
- Recent studies have highlighted the importance of nucleic acid quantitation in disease management, particularly in the case of viral infections such as HIV-1 and SARS-CoV2. In May 2022, an article published in the Journal Methods emphasized the significance of sensitive detection and quantitation of viral nucleic acids for disease management. The study demonstrated that sensitive HIV-1 DNA and RNA quantitation assays can aid in effectively treating and managing HIV-1 infection, including combination antiretroviral therapy (cART).
- Moreover, obtaining a pure and accurately quantitated amount of the target nucleic acid is crucial for several purposes, such as amplification, genetic engineering, and other applications. In February 2021, a study published in the Journal of Biological Methods highlighted the vast usage of agarose gel electrophoresis to isolate high-quality DNA, assess the quality of PCR products, and quantitate the nucleic acid, which can be beneficial to obtain quality, single-molecule DNA substrates.
- The high usage of nucleic acid quantification using gel electrophoresis, which requires gel documentation systems, is expected to drive the growth of the nucleic acid quantification segment. Furthermore, research investments in HIV have increased, which is also expected to drive the demand for gel documentation systems for HIV-related studies. According to data published by the United States Department of Health & Human Services in October 2022, the National Institute of Health (NIH) announced 66 awards to institutions participating in the NIMH AIDS Research Centers (ARC) programs and NIH-funded Centers for AIDS Research (CFAR) as part of the initiative to "End the HIV Epidemic in the United States (EHE)."
- Therefore, due to the importance and various applications of nucleic acid quantitation in research studies, as well as the increased demand for gel documentation systems for HIV-related studies, the nucleic acid quantification segment is expected to grow significantly over the forecast period.
North America is Expected to Witness Significant Growth Over the Forecast Period
- North America is expected to witness significant growth over the forecast period, owing to the high prevalence of chronic diseases, advanced healthcare infrastructure, and research investments. The increasing prevalence of chronic diseases in the region would create more demand for diagnosis and research of the target protein, biomarkers, and nucleic acid, which utilizes gel documentation systems for visualizing the protein/nucleic acid bands. For instance, according to the American Cancer Society, in 2023, over 1.9 million new cancer cases are expected to be diagnosed in the United States.
- Further, per the data published by the Canadian Cancer Society in 2023, over 233,900 new cancer cases were estimated in 2022. The region has a high burden of diabetes as well, which is expected to boost the demand for gel documentation systems for research. As per the data published by the Canadian Diabetes Association in June 2022, over 5.7 million Canadians were estimated to be diagnosed with type 1 or type 2 diabetes in 2022.
- Furthermore, the region has significant investments in cancer and other diseases, which would create more demand for the gel documentation system as they are used in imaging the electrophoresis gel to study the target protein. Thus, the increasing research in the North American region would boost the growth of the gel documentation market.
- For instance, in January 2023, the Canadian Institutes of Health Research of the Government of Canada (CIHR) invested over CAD 23 million (USD 16.83 million) into pediatric cancer in Canada. Further, in December 2022, Breast Cancer Canada announced a call for proposals for its 2023 Precision Oncology Research Grants, which would award over CAD 500,000 (USD 36,600) in its new funding for breast cancer research projects.
- The key developments and investments into research in the region are expected to create more demand for the gel documentation system for the research, which would boost the market in the region. For instance, in May 2023, The Lung Cancer Research Foundation (LCRF) collaborated with Daiichi Sankyo and AstraZeneca. Under the collaboration, LCRF and companies would fund three research grants focused on antibody-drug conjugates to improve the outcomes for lung cancer patients.
- Further, in January 2023, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine of the United States planned to invest in six new projects, which are focused on breast, prostate, neck and head cancer, lung, osteosarcoma, and neuroblastoma. Also, in January 2022, Novartis planned to invest over USD 50 million into clinical research in Mexico. The investment would strengthen the discovery of new drugs for diseases with unmet medical needs in the country and thus creates the demand for gel documentation systems and accessories and driving the market's growth.
- Therefore, owing to the factors above, including the increasing prevalence of diseases and increasing research investment into diseases, the growth of the studied market is anticipated in the North America Region.
Gel Documentation Systems Industry Overview
The gel documentation systems market is consolidated due to the presence of a few companies operating globally and regionally. The key market players include Bio-Rad Laboratories, Inc., Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd, and Merck KGaA.
Gel Documentation Systems Market Leaders
Bio-Rad Laboratories, Inc.
Syngene
Thermo Fisher Scientific
Cleaver Scientific Ltd
Merck KGaA
*Disclaimer: Major Players sorted in no particular order
Gel Documentation Systems Market News
- January 2023: Azure Biosystems Inc. launched its high-performance, personal chemiluminescent imaging system, chemiSOLO. The system can be controlled by a smartphone, laptop, or tablet through a novel web-based interface. The instrument offers LED lights for visible imaging of samples such as Coomassie-stained gels, pre-dyed color protein markers, and colorimetric Western blots.
- June 2022: Karkinos Healthcare launched its Advanced Centre for Cancer Diagnostics and Research in Kochi, India. The new State-of-the-art lab would serve as the central lab for the Karkinos global oncology network for the molecular and genomic analysis of the specimens, which would assist in the personalized, targeted therapy, predicting the possible response to the cancer therapy and evaluating the response by liquid biopsy.
Gel Documentation Systems Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidence of Chronic, Infectious Diseases and Genetic Disorders
4.2.2 Increasing Research Investment into the Genomic, Proteomics Techniques
4.3 Market Restraints
4.3.1 Growing Adoption of Alternative Techniques
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Products
5.1.1 Instruments
5.1.2 Software
5.1.3 Accessories
5.2 By Light Source
5.2.1 Light Emmiting Diodes
5.2.2 UV
5.2.3 Laser
5.3 By Detection Techniques
5.3.1 Ultraviolet
5.3.2 Chemiluminescence
5.3.3 Fluroscence
5.4 By Application
5.4.1 Nucleic Acid Quantification
5.4.2 Protein Quantification
5.4.3 Other Applications
5.5 By End-User
5.5.1 Diagnostic Labs
5.5.2 Pharamceutical Companies
5.5.3 Other End-Users
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 Syngene
6.1.4 Cleaver Scientific Ltd
6.1.5 Merck KGaA
6.1.6 Corning Incorporated
6.1.7 Labnet International, Inc.
6.1.8 Azure Biosystems, Inc.
6.1.9 Isogen Life Science
6.1.10 Analytik Jena AG
6.1.11 OPRL Biosciences Pvt.,Ltd
6.1.12 TechnoSource
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Gel Documentation Systems Industry Segmentation
As per the scope of the report, the gel documentation system is a gel analysis tool used on digital platforms to monitor and quantify stained agarose gel and acrylamide gels. This device has a comprehensive application for the documentation and imaging of proteins and nucleic acid stained in agarose gels in molecular biology laboratories and clinical research centers.
The gel documentation systems market is segmented by product (instruments, software, and accessories), light source (light emitting diodes, uv, and laser), detection techniques (ultraviolet, chemiluminescence, and fluorescence), application (nucleic acid quantification, protein quantification, and other applications), end-user (diagnostic labs, pharmaceutical companies, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD million) for the above segments.
| By Products | |
| Instruments | |
| Software | |
| Accessories |
| By Light Source | |
| Light Emmiting Diodes | |
| UV | |
| Laser |
| By Detection Techniques | |
| Ultraviolet | |
| Chemiluminescence | |
| Fluroscence |
| By Application | |
| Nucleic Acid Quantification | |
| Protein Quantification | |
| Other Applications |
| By End-User | |
| Diagnostic Labs | |
| Pharamceutical Companies | |
| Other End-Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Gel Documentation Systems Market Research FAQs
What is the current Gel Documentation Systems Market size?
The Gel Documentation Systems Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)
Who are the key players in Gel Documentation Systems Market?
Bio-Rad Laboratories, Inc., Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd and Merck KGaA are the major companies operating in the Gel Documentation Systems Market.
Which is the fastest growing region in Gel Documentation Systems Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gel Documentation Systems Market?
In 2024, the North America accounts for the largest market share in Gel Documentation Systems Market.
What years does this Gel Documentation Systems Market cover?
The report covers the Gel Documentation Systems Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gel Documentation Systems Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gel Documentation Systems Industry Report
Statistics for the 2024 Gel Documentation Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Gel Documentation Systems analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
